BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Taiwan

President Tsai Ing-wen Inaugurates Taiwan Healthcare+ Expo 2023, Showcasing Global Leadership in Healthcare Technology

Renowned for expertise in AI, cloud computing, IoT, 5G, and display technology, Taiwan has become a tech hub propelling biomedical progress. The expo, con...

December 01, 2023 | News

Senhwa Biosciences Granted FDA IND for Phase II Study of Silmitasertib in Viral Community-Acquired Pneumonia (CAP)

The trial is a phase II multi-center, randomized-controlled interventional prospective study, and the purpose of this trial is to investigate whether ...

November 22, 2023 | News

Taiwan Lubricate for academic research and health products development

In the collaboration with Lipotype GmbH, Germany (the world leader in lipidomics profiling service), T-BAL has developed advanced multi-omics (ma...

November 20, 2023 | News

TaiMed Reports Major Advances in Clinical Trials for New HIV Treatment in Taiwan

TaiMed Biologics, an innovation-driven biotech company dedicated to serving unmet healthcare needs, has announced favorable results and the successful comp...

October 17, 2023 | News

TaiGen Inks Exclusive Licensing Deal for New Drug in Malaysia and Singapore

TaiGen indicates that the agreement involves the development and marketing rights of the new drug in Malaysia and Singapore. Y.S.P...

October 12, 2023 | News

CANbridge's CAN108 (LIVMARLI®) Receives Approval in Taiwan for ALGS-Related Pruritus

CANbridge Pharmaceuticals Inc. (1228.HK), a global biopharmaceutical company, with a foundation in China, committed to the research, development ...

October 09, 2023 | News

Everest Medicines Gets Taiwan Approval for XERAVA® in Treating Intra-Abdominal Infections

"The NDA approval of XERAVA® in Taiwan marks an important step towards bringing this novel, critical therapy for complicated intra-abdominal ...

September 28, 2023 | News

'Bayer For Her' Supporting 365 Days Conversations of Care to More Women in Asia

Bayer Pharmaceuticals Division in Asia/Pacific announced in conjunction with World Contraception Day, the inception of its 'Bayer For Her' region...

September 25, 2023 | News

Caliway Completes Recruitment for CBL-514 Cellulite Treatment Phase 2 Study

The CBL-0201EFP Phase 2-stage 2 study is an open-label trial that will evaluate the efficacy, safety, and tolerability of CBL-514 in treating subjects with...

September 20, 2023 | News

Menarini Asia-Pacific and Astellas Sign Exclusive Licensing Deal for Smyraf® in Taiwan and SE Asian Markets

Subject to the terms of the agreement, Astellas will receive total payments of up to €5.5 million including upfront and milestone payments. In additio...

September 13, 2023 | News

DualityBio, BioNTech Expand Partnership for Solid Tumor Antibody-Drug Conjugate

The agreement further builds upon the strategic collaboration the companies announced in April 2023. Under the terms of the agreements, DualityBio will re...

August 08, 2023 | News

Bora Pharmaceuticals Introduces State-of-the-Art Facility in Taiwan to Produce Ophthalmic Products

Officially opened by Bora Pharmaceuticals CEO Bobby Sheng and President of Taiwan Operations Tom Chang, the facility will provide Bora’s customers wi...

August 07, 2023 | News

Fapon Unveils High-Throughput Chemiluminescence Immunoassay Analyzer

According to Mr. Kevin Liu, Global Sales Director of Fapon, "The Shine i8000/9000 Chemiluminescence Immunoassay Analyzer boasts an extraordinary testi...

July 26, 2023 | News

Antengene's XPOVIO® Approved in Hong Kong for Relapsed Multiple Myeloma

XPOVIO® has received regulatory approvals in 41 countries and regions including the United States, Israel, the United Kingdo...

July 17, 2023 | News

Stay Connected